Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Tetsuo Shoji

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Renal Dialysis

Concepts & Ideas

Anatomy

Chemicals & Drugs

Devices

Glucose Clamp Technique

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Shoji Tetsuo; Nishizawa Yoshiki
[Chronic kidney disease (CKD) and bone. Pleiotropic actions of vitamin D and survival advantage]
Lee Eiko; Emoto Masanori; Teramura Megumi; Tsuchikura Shoko; Ueno Hiroki; Shinohara Kayo; Morioka Tomoaki; Mori Katsuhito; Koyama Hidenori; Shoji Tetsuo; Okuno Yasuhisa; Inaba Masaaki; Nishizawa Yoshiki
The combination of IMT and stiffness parameter beta is highly associated with concurrent coronary artery disease in type 2 diabetes.
Araki Takahiro; Emoto Masanori; Konishi Toshiaki; Ikuno Yoshiko; Lee Eiko; Teramura Megumi; Motoyama Koka; Yokoyama Hisayo; Mori Katsuhito; Koyama Hidenori; Shoji Tetsuo; Nishizawa Yoshiki
Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Tetsuo Shoji (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Shoji Tetsuo; Nishizawa Yoshiki
[Chronic kidney disease (CKD) and bone. Pleiotropic actions of vitamin D and survival advantage]
Clinical calcium 2009;19(4):514-21.
2009: Lee Eiko; Emoto Masanori; Teramura Megumi; Tsuchikura Shoko; Ueno Hiroki; Shinohara Kayo; Morioka Tomoaki; Mori Katsuhito; Koyama Hidenori; Shoji Tetsuo; Okuno Yasuhisa; Inaba Masaaki; Nishizawa Yoshiki
The combination of IMT and stiffness parameter beta is highly associated with concurrent coronary artery disease in type 2 diabetes.
Journal of atherosclerosis and thrombosis 2009;16(1):33-9.
2009: Araki Takahiro; Emoto Masanori; Konishi Toshiaki; Ikuno Yoshiko; Lee Eiko; Teramura Megumi; Motoyama Koka; Yokoyama Hisayo; Mori Katsuhito; Koyama Hidenori; Shoji Tetsuo; Nishizawa Yoshiki
Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus.
Metabolism: clinical and experimental 2009;58(2):143-8.
2009: Shoji Tetsuo; Hatsuda Sawako; Tsuchikura Shoko; Shinohara Kayo; Kimoto Eiji; Koyama Hidenori; Emoto Masanori; Nishizawa Yoshiki
Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis.
Atherosclerosis 2009;202(2):582-8.
2008: Ueno Hiroki; Koyama Hidenori; Tanaka Shinji; Fukumoto Shinya; Shinohara Kayo; Shoji Tetsuo; Emoto Masanori; Tahara Hideki; Kakiya Ryusuke; Tabata Tsutomu; Miyata Toshio; Nishizawa Yoshiki
Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease.
Metabolism: clinical and experimental 2008;57(10):1452-7.
2008: Mori Katsuhito; Emoto Masanori; Araki Takahiro; Yokoyama Hisayo; Lee Eiko; Teramura Megumi; Koyama Hidenori; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2008;57(9):1248-52.
2008: Shoji Tetsuo; Tsubakihara Yoshiharu; Nakai Shigeru; Nishizawa Yoshiki
Reverse epidemiology in hemodialysis patients. Lessons from Japanese registries.
Néphrologie & thérapeutique 2008;4(4):223-7.
2008: Ishimura Eiji; Okuno Senji; Taniwaki Hiromichi; Kizu Akane; Tsuchida Takao; Shioi Atsushi; Shoji Tetsuo; Tabata Tsutomu; Inaba Masaaki; Nishizawa Yoshiki
Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
Kidney & blood pressure research 2008;31(1):10-5.
2007: Shoji Tetsuo; Ishimura Eiji; Nishizawa Yoshiki
Body fat measurement in chronic kidney disease: implications in research and clinical practice.
Current opinion in nephrology and hypertension 2007;16(6):572-6.
2007: Teramura Megumi; Emoto Masanori; Araki Takahiro; Yokoyama Hisayo; Motoyama Koka; Shinohara Kayo; Mori Katsuhito; Koyama Hidenori; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Clinical impact of metabolic syndrome by modified NCEP-ATPIII criteria on carotid atherosclerosis in Japanese adults.
Journal of atherosclerosis and thrombosis 2007;14(4):172-8.
2007: Ishimura Eiji; Taniwaki Hiromichi; Tsuchida Takao; Obatake Naoko; Emoto Masanori; Shoji Tetsuo; Shioi Atsushi; Inaba Masaaki; Nishizawa Yoshiki
Urinary albumin excretion associated with arterial wall stiffness rather than thickness in type 2 diabetic patients.
Journal of nephrology 2007;20(2):204-11.
2007: Mori Katsuhito; Emoto Masanori; Araki Takahiro; Yokoyama Hisayo; Teramura Megumi; Lee Eiko; Motoyama Koka; Koyama Hidenori; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Association of serum fetuin-A with carotid arterial stiffness.
Clinical endocrinology 2007;66(2):246-50.
2007: Koyama Hidenori; Shoji Tetsuo; Fukumoto Shinya; Shinohara Kayo; Shoji Takuhito; Emoto Masanori; Mori Katsuhito; Tahara Hideki; Ishimura Eiji; Kakiya Ryusuke; Tabata Tsutomu; Yamamoto Hiroshi; Nishizawa Yoshiki
Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(1):147-53.
2007: Koyama Hidenori; Shoji Tetsuo; Fukumoto Shinya; Shinohara Kayo; Shoji Takuhito; Emoto Masanori; Mori Katsuhito; Tahara Hideki; Ishimura Eiji; Kakiya Ryusuke; Tabata Tsutomu; Yamamoto Hiroshi; Nishizawa Yoshiki
Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(1):147-53.
2007: Hatsuda Sawako; Shoji Tetsuo; Shinohara Kayo; Kimoto Eiji; Mori Katsuhito; Fukumoto Shinya; Koyama Hidenori; Emoto Masanori; Nishizawa Yoshiki
Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects.
Journal of vascular research 2007;44(1):61-6.
2006: Shoji Takuhito; Koyama Hidenori; Fukumoto Shinya; Maeno Takaaki; Yokoyama Hisayo; Shinohara Kayo; Emoto Masanori; Shoji Tetsuo; Yamane Takahisa; Hino Masayuki; Shioi Atsushi; Nishizawa Yoshiki
Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis.
Atherosclerosis 2006;188(1):190-5.
2006: Shoji Takuhito; Koyama Hidenori; Fukumoto Shinya; Maeno Takaaki; Yokoyama Hisayo; Shinohara Kayo; Emoto Masanori; Shoji Tetsuo; Yamane Takahisa; Hino Masayuki; Shioi Atsushi; Nishizawa Yoshiki
Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis.
Atherosclerosis 2006;188(1):190-5.
2006: Shoji Tetsuo; Nishizawa Yoshiki
Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2006;10(4):305-15.
2006: Shoji Takuhito; Koyama Hidenori; Morioka Tomoaki; Tanaka Shinji; Kizu Akane; Motoyama Kohka; Mori Katsuhito; Fukumoto Shinya; Shioi Atsushi; Shimogaito Noriko; Takeuchi Masayoshi; Yamamoto Yasuhiko; Yonekura Hideto; Yamamoto Hiroshi; Nishizawa Yoshiki
Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Diabetes 2006;55(8):2245-55.
2006: Araki Takahiro; Emoto Masanori; Teramura Megumi; Yokoyama Hisayo; Mori Katsuhito; Hatsuda Sawako; Maeno Takaaki; Shinohara Kayo; Koyama Hidenori; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin.
Metabolism: clinical and experimental 2006;55(8):996-1001.
2006: Kimoto Eiji; Shoji Tetsuo; Shinohara Kayo; Hatsuda Sawako; Mori Katsuhito; Fukumoto Shinya; Koyama Hidenori; Emoto Masanori; Okuno Yasuhisa; Nishizawa Yoshiki
Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease.
Journal of the American Society of Nephrology : JASN 2006;17(8):2245-52.
2006: Kakiya R; Shoji T; Tsujimoto Y; Tatsumi N; Hatsuda S; Shinohara K; Kimoto E; Tahara H; Koyama H; Emoto M; Ishimura E; Miki T; Tabata T; Nishizawa Y
Body fat mass and lean mass as predictors of survival in hemodialysis patients.
Kidney international 2006;70(3):549-56.
2006: Nishizawa Yoshiki; Shoji Tetsuo
Does paricalcitol reduce proteinuria in patients with chronic kidney disease?
Nature clinical practice. Nephrology 2006;2(7):352-3.
2006: Nishizawa Yoshiki; Shoji Tetsuo; Ishimura Eiji
Body composition and cardiovascular risk in hemodialysis patients.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2006;16(3):241-4.
2006: Shoji Tetsuo; Nishizawa Yoshiki
[Effects of vitamin D on the cardiovascular system]
Clinical calcium 2006;16(7):1107-14.
2006: Oomichi Takeshi; Emoto Masanori; Tabata Tsutomu; Morioka Tomoaki; Tsujimoto Yoshihiro; Tahara Hideki; Shoji Tetsuo; Nishizawa Yoshiki
Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study.
Diabetes care 2006;29(7):1496-500.
2006: Araki Takahiro; Emoto Masanori; Yokoyama Hisayo; Maeno Takaaki; Hatsuda Sawako; Mori Katsuhito; Koyama Hidenori; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
The association of plasma adiponectin level with carotid arterial stiffness.
Metabolism: clinical and experimental 2006;55(5):587-92.
2006: Hatsuda Sawako; Shoji Tetsuo; Shinohara Kayo; Kimoto Eiji; Mori Katsuhito; Fukumoto Shinya; Koyama Hidenori; Emoto Masanori; Nishizawa Yoshiki
Regional arterial stiffness associated with ischemic heart disease in type 2 diabetes mellitus.
Journal of atherosclerosis and thrombosis 2006;13(2):114-21.
2006: Yokoyama Hisayo; Emoto Masanori; Mori Katsuhito; Araki Takahiro; Teramura Megumi; Koyama Hidenori; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.
The Journal of clinical endocrinology and metabolism 2006;91(1):290-4.
2005: Koyama Hidenori; Shoji Takuhito; Yokoyama Hisayo; Motoyama Kohka; Mori Katsuhito; Fukumoto Shinya; Emoto Masanori; Shoji Tetsuo; Tamei Hironori; Matsuki Hirokazu; Sakurai Shigeru; Yamamoto Yasuhiko; Yonekura Hideto; Watanabe Takuo; Yamamoto Hiroshi; Nishizawa Yoshiki
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(12):2587-93.
2005: Koyama Hidenori; Shoji Takuhito; Yokoyama Hisayo; Motoyama Kohka; Mori Katsuhito; Fukumoto Shinya; Emoto Masanori; Shoji Tetsuo; Tamei Hironori; Matsuki Hirokazu; Sakurai Shigeru; Yamamoto Yasuhiko; Yonekura Hideto; Watanabe Takuo; Yamamoto Hiroshi; Nishizawa Yoshiki
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(12):2587-93.
2005: Taniwaki Hiromichi; Ishimura Eiji; Tabata Tsutomu; Tsujimoto Yoshihiro; Shioi Atushi; Shoji Tetsuo; Inaba Masaaki; Inoue Takashi; Nishizawa Yoshiki
Aortic calcification in haemodialysis patients with diabetes mellitus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(11):2472-8.
2005: Tahara Hideki; Tsujimoto Yoshihiro; Shoji Tetsuo; Inaba Masaaki; Tabata Tsutomu; Nishizawa Yoshiki
Introduction to sevelamer hydrochloride and its clinical effects.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2005;9 Suppl 1():S2-6.
2005: Araki Takahiro; Emoto Masanori; Yokoyama Hisayo; Motoyama Koka; Morioka Tomoaki; Tahara Hideki; Koyama Hidenori; Shoji Tetsuo; Okuno Yasuhisa; Inaba Masaaki; Nishizawa Yoshiki
Insulin resistance index as a predictor for pioglitazone treatment in type 2 diabetes.
Osaka city medical journal 2005;51(1):19-25.
2005: Ishimura Eiji; Taniwaki Hiromichi; Tabata Tsutomu; Tsujimoto Yoshihiro; Jono Shuichi; Emoto Masanori; Shoji Tetsuo; Inaba Masaaki; Inoue Takashi; Nishizawa Yoshiki
Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(5):859-65.
2005: Shoji Tetsuo; Nishizawa Yoshiki
Chronic kidney disease as a metabolic syndrome with malnutrition--need for strict control of risk factors.
Internal medicine (Tokyo, Japan) 2005;44(3):179-87.
2005: Yokoyama Hisayo; Tahara Hideki; Emoto Masanori; Fujiwara Shigehiko; Araki Takahiro; Shinohara Kayo; Hatsuda Sawako; Maeno Takaaki; Shoji Takuhito; Koyama Hidenori; Shoji Tetsuo; Nishizawa Yoshiki
The K469E polymorphism of the intercellular adhesion molecule-1 gene is associated with plasma fibrinogen level in type 2 diabetes.
Metabolism: clinical and experimental 2005;54(3):381-6.
2005: Yokoyama Hisayo; Tahara Hideki; Emoto Masanori; Fujiwara Shigehiko; Araki Takahiro; Shinohara Kayo; Hatsuda Sawako; Maeno Takaaki; Shoji Takuhito; Koyama Hidenori; Shoji Tetsuo; Nishizawa Yoshiki
The K469E polymorphism of the intercellular adhesion molecule-1 gene is associated with plasma fibrinogen level in type 2 diabetes.
Metabolism: clinical and experimental 2005;54(3):381-6.
2005: Shoji Tetsuo; Shinohara Kayo; Hatsuda Sawako; Kimoto Eiji; Fukumoto Shinya; Emoto Masanori; Tahara Hideki; Koyama Hidenori; Ishimura Eiji; Miki Takami; Tabata Tsutomu; Nishizawa Yoshiki
Altered relationship between body fat and plasma adiponectin in end-stage renal disease.
Metabolism: clinical and experimental 2005;54(3):330-4.
2005: Yamada Shinsuke; Inaba Masaaki; Goto Hitoshi; Nagata Mayumi; Ueda Misako; Nakatuka Kiyoshi; Tahara Hideki; Yokoyama Hisayo; Emoto Masanori; Shoji Tetsuo; Nishizawa Yoshiki
Significance of intima-media thickness in femoral artery in the determination of calcaneus osteo-sono index but not of lumbar spine bone mass in healthy Japanese people.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(1):64-70.
2005: Shoji Takuhito; Koyama Hidenori; Fukumoto Shinya; Maeno Takaaki; Yokoyama Hisayo; Shinohara Kayo; Emoto Masanori; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Platelet-monocyte aggregates are independently associated with occurrence of carotid plaques in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2005;12(6):344-52.
2005: Shoji Takuhito; Koyama Hidenori; Fukumoto Shinya; Maeno Takaaki; Yokoyama Hisayo; Shinohara Kayo; Emoto Masanori; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Platelet-monocyte aggregates are independently associated with occurrence of carotid plaques in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2005;12(6):344-52.
2005: Shinohara Kayo; Shoji Tetsuo; Kimoto Eiji; Yokoyama Hisayo; Fujiwara Shigehiko; Hatsuda Sawako; Maeno Takaaki; Shoji Takuhito; Fukumoto Shinya; Emoto Masanori; Koyama Hidenori; Nishizawa Yoshiki
Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus.
Journal of atherosclerosis and thrombosis 2005;12(4):205-10.
2005: Shinohara Kayo; Shoji Tetsuo; Kimoto Eiji; Yokoyama Hisayo; Fujiwara Shigehiko; Hatsuda Sawako; Maeno Takaaki; Shoji Takuhito; Fukumoto Shinya; Emoto Masanori; Koyama Hidenori; Nishizawa Yoshiki
Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus.
Journal of atherosclerosis and thrombosis 2005;12(4):205-10.
2004: Shoji Tetsuo; Nishizawa Yoshiki
[Vitamin D and survival of hemodialysis patients]
Clinical calcium 2004;14(9):64-8.
2004: Nishizawa Yoshiki; Shoji Tetsuo; Emoto Masanori; Koyama Hideki; Tahara Hideki; Fukumoto Shinya; Inaba Masaaki; Ishimura Eiji; Miki Takami
Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: another form of metabolic syndrome.
Seminars in nephrology 2004;24(5):423-5.
2004: Ishimura Eiji; Okuno Senji; Kitatani Kayoko; Maekawa Kiyoshi; Izumotani Tsuyoshi; Yamakawa Tomoyuki; Jono Shuichi; Shoji Tetsuo; Shioi Atsushi; Inaba Masaaki; Massry Shaul G; Nishizawa Yoshiki
C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries.
Seminars in nephrology 2004;24(5):408-12.
2004: Yokoyama Hisayo; Emoto Masanori; Fujiwara Shigehiko; Motoyama Koka; Morioka Tomoaki; Koyama Hidenori; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Short-term aerobic exercise improves arterial stiffness in type 2 diabetes.
Diabetes research and clinical practice 2004;65(2):85-93.
2004: Yokoyama Hisayo; Emoto Masanori; Araki Takahiro; Fujiwara Shigehiko; Motoyama Koka; Morioka Tomoaki; Koyama Hidenori; Shoji Tetsuo; Okuno Yasuhisa; Nishizawa Yoshiki
Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes.
Diabetes care 2004;27(7):1756-8.
2004: Shoji Tetsuo; Kimoto Eiji; Shinohara Kayo; Hatsuda Sawako; Nishizawa Yoshiki
Molecular forms of adiponectin in uraemic plasma.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(7):1937-8.
2004: Shoji Tetsuo; Nishizawa Yoshiki
[Arteriosclerosis in renal failure]
Nippon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 6():339-42.
2004: Okabe Reiko; Inaba Masaaki; Sakai Shinrei; Ishimura Eiji; Moriguchi Atsushi; Shoji Tetsuo; Nishizawa Yoshiki
Increased arterial stiffening and thickening in the paretic lower limb in patients with hemiparesis.
Clinical science (London, England : 1979) 2004;106(6):613-8.
2004: Imanishi Yasuo; Inaba Masaaki; Nakatsuka Kiyoshi; Nagasue Kyoko; Okuno Senji; Yoshihara Asami; Miura Masakazu; Miyauchi Akimitsu; Kobayashi Keisuke; Miki Takami; Shoji Tetsuo; Ishimura Eiji; Nishizawa Yoshiki
FGF-23 in patients with end-stage renal disease on hemodialysis.
Kidney international 2004;65(5):1943-6.
2004: Lee Eiko; Tahara Hideki; Shoji Takuhito; Nagata Mayumi; Ueda Misako; Yamada Shinsuke; Goto Hitoshi; Inaba Masaaki; Nishizawa Yoshiki
[Case Report No.138:One case of advanced renal hyperparathyroidim complicated with acute renal failure.]
Clinical calcium 2004;14(3):462-5.
2004: Yokoyama Hisayo; Emoto Masanori; Fujiwara Shigehiko; Motoyama Koka; Morioka Tomoaki; Komatsu Miyoko; Tahara Hideki; Koyama Hidenori; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose.
The Journal of clinical endocrinology and metabolism 2004;89(3):1481-4.
2004: Shinohara Kayo; Shoji Tetsuo; Tsujimoto Yoshihiro; Kimoto Eiji; Tahara Hideki; Koyama Hidenori; Emoto Masanori; Ishimura Eiji; Miki Takami; Tabata Tsutomu; Nishizawa Yoshiki
Arterial stiffness in predialysis patients with uremia.
Kidney international 2004;65(3):936-43.
2004: Shoji Tetsuo; Shinohara Kayo; Kimoto Eiji; Emoto Masanori; Tahara Hideki; Koyama Hidenori; Inaba Masaaki; Fukumoto Shinya; Ishimura Eiji; Miki Takami; Tabata Tsutomu; Nishizawa Yoshiki
Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(1):179-84.
2003: Okuno Senji; Ishimura Eiji; Kitatani Kayoko; Chou Hidenori; Nagasue Kyoko; Maekawa Kiyoshi; Izumotani Tsuyoshi; Yamakawa Tomoyuki; Imanishi Yasuo; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(12):2613-21.
2003: Nagata-Sakurai Mayumi; Inaba Masaaki; Goto Hitoshi; Kumeda Yasuro; Furumitsu Yutaka; Inui Kentaro; Koyama Hidenori; Emoto Masanori; Ishimura Eiji; Shoji Tetsuo; Nishizawa Yoshiki
Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis.
Arthritis and rheumatism 2003;48(11):3061-7.
2003: Kizu Akane; Koyama Hidenori; Tanaka Shinji; Maeno Takaaki; Komatsu Miyoko; Fukumoto Shinya; Emoto Masanori; Shoji Tetsuo; Inaba Masaaki; Shioi Atsushi; Miki Takami; Nishizawa Yoshiki
Arterial wall stiffness is associated with peripheral circulation in patients with type 2 diabetes.
Atherosclerosis 2003;170(1):87-91.
2003: Yokoyama Hisayo; Emoto Masanori; Fujiwara Shigehiko; Motoyama Koka; Morioka Tomoaki; Komatsu Miyoko; Tahara Hideki; Shoji Tetsuo; Okuno Yasuhisa; Nishizawa Yoshiki
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients.
Diabetes care 2003;26(8):2426-32.
2003: Koyama Hidenori; Maeno Takaaki; Fukumoto Shinya; Shoji Takuhito; Yamane Takahisa; Yokoyama Hisayo; Emoto Masanori; Shoji Tetsuo; Tahara Hideki; Inaba Masaaki; Hino Masayuki; Shioi Atsushi; Miki Takami; Nishizawa Yoshiki
Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans.
Circulation 2003;108(5):524-9.
2003: Koyama Hidenori; Maeno Takaaki; Fukumoto Shinya; Shoji Takuhito; Yamane Takahisa; Yokoyama Hisayo; Emoto Masanori; Shoji Tetsuo; Tahara Hideki; Inaba Masaaki; Hino Masayuki; Shioi Atsushi; Miki Takami; Nishizawa Yoshiki
Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans.
Circulation 2003;108(5):524-9.
2003: Motoyama Koka; Emoto Masanori; Tahara Hideki; Komatsu Miyoko; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Association of muscle glycogen synthase polymorphism with insulin resistance in type 2 diabetic patients.
Metabolism: clinical and experimental 2003;52(7):895-9.
2003: Ueda Hideki; Ishimura Eiji; Shoji Tetsuo; Emoto Masanori; Morioka Tomoaki; Matsumoto Naoki; Fukumoto Shinya; Miki Takami; Inaba Masaaki; Nishizawa Yoshiki
Factors affecting progression of renal failure in patients with type 2 diabetes.
Diabetes care 2003;26(5):1530-4.
2003: Shoji Tetsuo; Kimoto Eiji; Shinohara Kayo; Emoto Masanori; Ishimura Eiji; Miki Takami; Tsujimoto Yoshihiro; Tabata Tsutomu; Nishizawa Yoshiki
The association of antibodies against oxidized low-density lipoprotein with atherosclerosis in hemodialysis patients.
Kidney international. Supplement 2003;(84):S128-30.
2003: Nishizawa Yoshiki; Shoji Tetsuo; Kakiya Ryusuke; Tsujimoto Yoshihiro; Tabata Tsutomu; Ishimura Eiji; Nakatani Tatsuya; Miki Takami; Inaba Masaaki
Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.
Kidney international. Supplement 2003;(84):S117-20.
2003: Ishimura Eiji; Okuno Senji; Marukawa Taro; Katoh Yoshikazu; Hiranaka Toshiyuki; Yamakawa Tomoyuki; Morii Hirotoshi; Kim Masao; Matsumoto Naoki; Shoji Tetsuo; Inaba Masaaki; Nakatani Tatsuya; Nishizawa Yoshiki
Body fat mass in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S137-41.
2003: Nishizawa Yoshiki; Shoji Tetsuo; Maekawa Kiyoshi; Nagasue Kyoko; Okuno Senji; Kim Masao; Emoto Masanori; Ishimura Eiji; Nakatani Tatsuya; Miki Takami; Inaba Masaaki
Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S76-9.
2003: Kimoto Eiji; Shoji Tetsuo; Shinohara Kayo; Inaba Masaaki; Okuno Yasuhisa; Miki Takami; Koyama Hidenori; Emoto Masanori; Nishizawa Yoshiki
Preferential stiffening of central over peripheral arteries in type 2 diabetes.
Diabetes 2003;52(2):448-52.
2003: Taniwaki Hiromichi; Ishimura Eiji; Kawagishi Takahiko; Matsumoto Naoki; Hosoi Masayuki; Emoto Masanori; Shoji Tetsuo; Shoji Shigeichi; Nakatani Tatsuya; Inaba Masaaki; Nishizawa Yoshiki
Intrarenal hemodynamic changes after captopril test in patients with type 2 diabetes: a duplex Doppler sonography study.
Diabetes care 2003;26(1):132-7.
2003: Yokoyama Hisayo; Shoji Tetsuo; Kimoto Eiji; Shinohara Kayo; Tanaka Shinji; Koyama Hidenori; Emoto Masanori; Nishizawa Yoshiki
Pulse wave velocity in lower-limb arteries among diabetic patients with peripheral arterial disease.
Journal of atherosclerosis and thrombosis 2003;10(4):253-8.
2003: Fujiwara Shigehiko; Emoto Masanori; Komatsu Miyoko; Motoyama Koka; Morioka Tomoaki; Koyama Hidenori; Shoji Tetsuo; Inaba Masaaki; Nishizawa Yoshiki
Arterial wall thickness is associated with insulin resistance in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2003;10(4):246-52.
2002: Shoji Tetsuo; Fukumoto Mariko; Kimoto Eiji; Shinohara Kayo; Emoto Masanori; Tahara Hideki; Koyama Hidenori; Ishimura Eiji; Nakatani Tatsuya; Miki Takami; Tsujimoto Yoshihiro; Tabata Tsutomu; Nishizawa Yoshiki
Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease.
Kidney international 2002;62(6):2230-7.
2002: Ishimura E; Okuno S; Kitatani K; Kim M; Shoji T; Nakatani T; Inaba M; Nishizawa Y
Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients--importance of glycaemic control.
Diabetologia 2002;45(10):1446-8.
2002: Komatsu Miyoko; Kawagishi Takahiko; Emoto Masanori; Shoji Tetsuo; Yamada Atsuko; Sato Kyoko; Hosoi Masayuki; Nishizawa Yoshiki
ecNOS gene polymorphism is associated with endothelium-dependent vasodilation in Type 2 diabetes.
American journal of physiology. Heart and circulatory physiology 2002;283(2):H557-61.
2002: Shinohara Kayo; Shoji Tetsuo; Emoto Masanori; Tahara Hideki; Koyama Hidenori; Ishimura Eiji; Miki Takami; Tabata Tsutomu; Nishizawa Yoshiki
Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease.
Journal of the American Society of Nephrology : JASN 2002;13(7):1894-900.
2002: Kawasaki Isao; Tahara Hideki; Emoto Masanori; Shoji Tetsuo; Shioji Atsushi; Okuno Yasuhisa; Inaba Masaaki; Nishizawa Yoshiki
Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.
Osaka city medical journal 2002;48(1):23-8.
2002: Kumeda Yasuro; Inaba Masaaki; Goto Hitoshi; Nagata Mayumi; Henmi Yasuko; Furumitsu Yutaka; Ishimura Eiji; Inui Kentaro; Yutani Yasutaka; Miki Takami; Shoji Tetsuo; Nishizawa Yoshiki
Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis.
Arthritis and rheumatism 2002;46(6):1489-97.
2002: Inaba Masaaki; Nagasue Kyoko; Okuno Senji; Ueda Misako; Kumeda Yasuro; Imanishi Yasuo; Shoji Tetsuo; Ishimura Eiji; Ohta Tomohiro; Nakatani Tatsuya; Kim Masao; Nishizawa Yoshiki
Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(6):1261-9.
2002: Shoji Tetsuo; Emoto Masanori; Tabata Tsutomu; Kimoto Eiji; Shinohara Kayo; Maekawa Kiyoshi; Kawagishi Takahiko; Tahara Hideki; Ishimura Eiji; Nishizawa Yoshiki
Advanced atherosclerosis in predialysis patients with chronic renal failure.
Kidney international 2002;61(6):2187-92.
2002: Ueda Hideki; Isimura Eiji; Okuno Senji; Maekawa Kiyoshi; Izumotani Tsuyoshi; Kim Masao; Matsumoto Naoki; Fukumoto Shinya; Imanishi Yasuo; Emoto Masanori; Shoji Tetsuo; Wanibuchi Hideki; Inaba Masaaki; Nishizawa Yoshiki
[Sibling cases of nephritis resembling membranoproliferative glomerulonephritis]
Nippon Jinzo Gakkai shi 2002;44(4):420-6.
2002: Maeno Takaaki; Koyama Hidenori; Tahara Hideki; Komatsu Miyoko; Emoto Masanori; Shoji Tetsuo; Inaba Masaaki; Miki Takami; Okuno Yasuhisa; Nishizawa Yoshiki
The 807T allele in alpha2 integrin is protective against atherosclerotic arterial wall thickening and the occurrence of plaque in patients with type 2 diabetes.
Diabetes 2002;51(5):1523-8.
2002: Matsumoto Naoki; Ishimura Eiji; Taniwaki Hiromichi; Emoto Masanori; Shoji Tetsuo; Kawagishi Takahiko; Inaba Masaaki; Nishizawa Yoshiki
Smoking and proteinuria impair vasodilatory response of intrarenal arteries to nitroglycerine in patients with type 2 diabetes mellitus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(4):608-13.
2002: Kawasaki Isao; Tahara Hideki; Emoto Masanori; Shoji Tetsuo; Nishizawa Yoshiki
Relationship between TaqIB cholesteryl ester transfer protein gene polymorphism and macrovascular complications in Japanese patients with type 2 diabetes.
Diabetes 2002;51(3):871-4.
2002: Kimoto Eiji; Shoji Tetsuo; Emoto Masonori; Miki Takami; Tabata Tsutomu; Okuno Yasuhisa; Ishimura Eiji; Inaba Masaaki; Nishizawa Yoshiki
Effect of diabetes on uremic dyslipidemia.
Journal of atherosclerosis and thrombosis 2002;9(6):305-13.
2001: Shoji T; Emoto M; Nishizawa Y
HOMA index to assess insulin resistance in renal failure patients.
Nephron 2001;89(3):348-9.
2001: Ishimura E; Shoji T; Emoto M; Motoyama K; Shinohara K; Matsumoto N; Taniwaki H; Inaba M; Nishizawa Y
Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S186-90.
2001: Shoji T; Ishimura E; Inaba M; Tabata T; Nishizawa Y
Atherogenic lipoproteins in end-stage renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S30-3.
2001: Nishizawa Y; Shoji T; Ishimura E; Inaba M; Morii H
Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S4-7.
2001: Shoji T; Emoto M; Shinohara K; Kakiya R; Tsujimoto Y; Kishimoto H; Ishimura E; Tabata T; Nishizawa Y
Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease.
Journal of the American Society of Nephrology : JASN 2001;12(10):2117-24.
2001: Ishimura E; Okuno S; Kim M; Yamamoto T; Izumotani T; Otoshi T; Shoji T; Inaba M; Nishizawa Y
Increasing body fat mass in the first year of hemodialysis.
Journal of the American Society of Nephrology : JASN 2001;12(9):1921-6.
2001: Taniwaki H; Shoji T; Emoto M; Kawagishi T; Ishimura E; Inaba M; Okuno Y; Nishizawa Y
Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus.
Atherosclerosis 2001;158(1):207-14.
2001: Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
Metabolism: clinical and experimental 2001;50(7):805-11.
2001: Shoji T; Emoto M; Kawagishi T; Kimoto E; Yamada A; Tabata T; Ishimura E; Inaba M; Okuno Y; Nishizawa Y
Atherogenic lipoprotein changes in diabetic nephropathy.
Atherosclerosis 2001;156(2):425-33.
2001: Morioka T; Emoto M; Tabata T; Shoji T; Tahara H; Kishimoto H; Ishimura E; Nishizawa Y
Glycemic control is a predictor of survival for diabetic patients on hemodialysis.
Diabetes care 2001;24(5):909-13.
2001: Shoji T; Nishizawa Y
[Multiple risk factor syndrome]
Nippon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 3():130-5.
2001: Emoto M; Kanda H; Shoji T; Kawagishi T; Komatsu M; Mori K; Tahara H; Ishimura E; Inaba M; Okuno Y; Nishizawa Y
Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes.
Diabetes care 2001;24(3):533-8.
2000: Shoji T; Kawagishi T; Emoto M; Maekawa K; Taniwaki H; Kanda H; Nishizawa Y
Additive impacts of diabetes and renal failure on carotid atherosclerosis.
Atherosclerosis 2000;153(1):257-8.
2000: Shoji T; Kimoto E; Yamada A; Emoto M; Kawagishi T; Tabata T; Nishizawa Y
Elevated plasma free apo(a) levels in hemodialysis patients.
Nephron 2000;86(3):389-90.
2000: Matsumoto N; Ishimura E; Taniwaki H; Emoto M; Shoji T; Kawagishi T; Inaba M; Nishizawa Y
Diabetes mellitus worsens intrarenal hemodynamic abnormalities in nondialyzed patients with chronic renal failure.
Nephron 2000;86(1):44-51.
2000: Taniwaki H; Ishimura E; Emoto M; Kawagishi T; Matsumoto N; Shoji T; Okamura T; Inaba M; Nishizawa Y
Relationship between urinary albumin excretion and glomerular filtration rate in normotensive, nonproteinuric patients with type 2 diabetes mellitus.
Nephron 2000;86(1):36-43.
2000: Fukumoto M; Shoji T; Emoto M; Kawagishi T; Okuno Y; Nishizawa Y
Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(3):703-7.
2000: Shoji T; Nishizawa Y; Fukumoto M; Shimamura K; Kimura J; Kanda H; Emoto M; Kawagishi T; Morii H
Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects.
Atherosclerosis 2000;148(1):171-7.
1999: Tsujimoto Y; Shoji T; Tabata T; Morita A; Emoto M; Nishizawa Y; Morii H
Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(5):832-8.
1999: Taniwaki H; Kawagishi T; Emoto M; Shoji T; Hosoi M; Kogawa K; Nishizawa Y; Morii H
Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.
Diabetes care 1999;22(11):1858-64.
1999: Taniwaki H; Kawagishi T; Emoto M; Shoji T; Kanda H; Maekawa K; Nishizawa Y; Morii H
Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
Diabetes care 1999;22(11):1851-7.
1999: Nishizawa Y; Shoji T; Tabata T; Inoue T; Morii H
Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients.
Kidney international. Supplement 1999;71():S134-6.
1999: Emoto M; Nishizawa Y; Maekawa K; Hiura Y; Kanda H; Kawagishi T; Shoji T; Okuno Y; Morii H
Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
Diabetes care 1999;22(5):818-22.
1998: Emoto M; Nishizawa Y; Kawagishi T; Maekawa K; Hiura Y; Kanda H; Izumotani K; Shoji T; Ishimura E; Inaba M; Okuno Y; Morii H
Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM.
Diabetes care 1998;21(7):1178-82.
1998: Shoji T; Nishizawa Y; Kawagishi T; Kawasaki K; Taniwaki H; Tabata T; Inoue T; Morii H
Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.
Journal of the American Society of Nephrology : JASN 1998;9(7):1277-84.
1998: Nishizawa Y; Shoji T; Tanaka S; Yamashita M; Morita A; Emoto M; Tabata T; Inoue T; Morii H
Plasma leptin level and its relationship with body composition in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(4):655-61.
1997: Nishizawa Y; Shoji T; Kawagishi T; Morii H
Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation.
Kidney international. Supplement 1997;62():S90-2.
1997: Shoji T; Nishizawa Y; Emoto M; Maekawa K; Hiura Y; Tanaka S; Kawagishi T; Okuno Y; Morii H
Renal function and insulin resistance as determinants of plasma leptin levels in patients with NIDDM.
Diabetologia 1997;40(6):676-9.
1997: Shoji T; Nishizawa Y; Kawagishi T; Tanaka M; Kawasaki K; Tabata T; Inoue T; Morii H
Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
Atherosclerosis 1997;131(2):229-36.
1997: Kogawa K; Nishizawa Y; Hosoi M; Kawagishi T; Maekawa K; Shoji T; Okuno Y; Morii H
Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness.
Diabetes 1997;46(4):682-7.
1996: Hosoi M; Nishizawa Y; Kogawa K; Kawagishi T; Konishi T; Maekawa K; Emoto M; Fukumoto S; Shioi A; Shoji T; Inaba M; Okuno Y; Morii H
Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients.
Circulation 1996;94(4):704-7.
1995: Kawagishi T; Nishizawa Y; Konishi T; Kawasaki K; Emoto M; Shoji T; Tabata T; Inoue T; Morii H
High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia.
Kidney international 1995;48(3):820-6.
1995: Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
Clinical nephrology 1995;43(4):268-77.
1993: Nishizawa Y; Shoji T; Nishitani H; Yamakawa M; Konishi T; Kawasaki K; Morii H
Hypertriglyceridemia and lowered apolipoprotein C-II/C-III ratio in uremia: effect of a fibric acid, clinofibrate.
Kidney international 1993;44(6):1352-9.
1992: Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.
Clinical nephrology 1992;38(5):271-6.
1992: Shoji T; Nishizawa Y; Koyama H; Hagiwara S; Aratani H; Sasao K; Kishimoto H; Tanishita H; Morii H
High-density-lipoprotein metabolism during a very-low-calorie diet.
The American journal of clinical nutrition 1992;56(1 Suppl):297S-298S.
1992: Nishizawa Y; Koyama H; Shoji T; Tahara H; Hagiwara S; Aratani H; Nakatsuka K; Miki T; Morii H
Altered calcium homeostasis accompanying changes of regional bone mineral during a very-low-calorie diet.
The American journal of clinical nutrition 1992;56(1 Suppl):265S-267S.
1992: Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
Impaired metabolism of high density lipoprotein in uremic patients.
Kidney international 1992;41(6):1653-61.
1991: Nishizawa Y; Koyama H; Shoji T; Aratani H; Hagiwara S; Miki T; Morii H
Obesity as a determinant of regional bone mineral density.
Journal of nutritional science and vitaminology 1991;37 Suppl():S65-70.
1991: Shoji T; Nishizawa Y; Koyama H; Hagiwara S; Aratani H; Izumotani-Sasao K; Kishimoto H; Tanishita H; Morii H
Lipoprotein metabolism in normolipidemic obese women during very low calorie diet: changes in high density lipoprotein.
Journal of nutritional science and vitaminology 1991;37 Suppl():S57-64.
1991: Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis.
Metabolism: clinical and experimental 1991;40(10):1002-8.
1991: Koyama H; Tahara H; Shoji T; Nishizawa Y; Inaba M; Otani S; Yanagisawa M; Ishiguro Y; Takanashi N; Morii H
Uremic serum contains humoral factor(s) larger than fifty kilodaltons which suppresses endothelin production in cultured endothelial cells.
Contributions to nephrology 1991;90():111-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Tetsuo Shoji

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Anatomy

Chemicals & Drugs

Devices

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Tetsuo Shoji (preview)

All Publications